Study compares COVID-19 vaccines’ ability to stimulate immune protection against the coronavirus
The analysis also compares rates of COVID-19 infection among people inoculated with each vaccine.
Dr. Iafrate is a Professor of Pathology at Harvard Medical School, former Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics at Massachusetts General Hospital and is currently the Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH). Dr. Iafrate received his MD/PhD dual degree from the State University of New York at Stony Brook in 2000 and was trained in anatomic and molecular genetic pathology at Brigham and Women’s Hospital. Dr. Iafrate is a board-certified Pathologist and has been on staff at MGH since 2005. The CID provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. His research is focused on lung and brain tumors, where he has been closely involved in the clinical development of crizotinib and companion diagnostics in ALK- and ROS1 positive lung cancers. His lab has developed several technologies for sequencing tumors, including SNaPshot and the next-generation sequencing-based Anchored Multiplex PCR, both techniques have been widely used in the molecular diagnostics community.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research in the Iafrate laboratory focuses on bringing new genetic technologies to cancer diagnostics and their application to the practice of pathology. Initially research focused on lung cancer, but our approach is expanding to all malignancies. For more information about research concepts, co-authors, and to see a timeline, visit Dr. Iafrate's profile at the Harvard Clinical and Translational Science Center.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General has two proton therapy centers and is the only hospital in New England to offer proton therapy on site.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
The analysis also compares rates of COVID-19 infection among people inoculated with each vaccine.
Using a method developed for HIV, researchers have identified stable T cell vaccine targets in SARS-CoV-2.
Las pruebas y el rastreo generalizados son esenciales para controlar la propagación del COVID-19, pero hay varios tipos de pruebas diferentes, y cada una tiene un uso específico.
John Iafrate, MD, PhD, y Edward Ryan, MD, desglosan los fundamentos sobre anticuerpos, pruebas de serología y las posibles implicaciones de una presencia positiva de anticuerpos en el caso del COVID-19.
John Iafrate, MD, PhD, and Edward Ryan, MD, break down the basics about antibodies, serology testing and the potential implications of a positive antibody presence in the case of COVID-19.